OmniAb, Inc. Warrant 2022- on Omniab Inc OABIW 深 滬
等待開盤 01-28 09:30:00 美东时间
0.111
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 0.111
- 總市值 0
- 52周最高 0.6275
- 市盈率 靜 --
- 換手率 NaN.00%
- 52周最低 0.0751
- 委 比 -25.21%
- 總股本 --
- 歷史最高 1.50
- 量 比 0
- 振 幅 0.00%
- 歷史最低 0.0751
- 每 手 1
- 風險率 0.12%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多OmniAb And Arrowmark Partners Sign A License And Services Agreement For Novel OmniAb-Derived Antibody Discovery Programs With Mabtrx Biosciences; OmniAb To Receive Revenue For Discovery Services As Well As Potential Equity And Royalties
OmniAb, Inc. (NASDAQ:OABI) and ArrowMark Partners ("ArrowMark") today announced the signing of a license and services agreement for novel OmniAb-derived antibody discovery programs with Mabtrx Biosciences, a wholly owned
2025-11-18 06:28
OmniAb to raise $30M in private stock placement
OmniAb (NASDAQ:OABI) has entered into a definitive agreement for a private placement of its common stock to raise approximately $30 million in gross proceeds. The company will issue and sell a total o...
2025-08-25 19:34
OmniAb Announces $30M Private Placement Agreement
An update from OmniAb ( ($OABI) ) is now available. On August 24, 2025, OmniAb,...
2025-08-25 19:28
RBC Capital Maintains Outperform on OmniAb, Lowers Price Target to $3
RBC Capital analyst Conor McNamara maintains OmniAb (NASDAQ:OABI) with a Outperform and lowers the price target from $4 to $3.
2025-08-07 23:11
CORRECTION: OmniAb Q2 EPS $(0.15) Beats $(0.16) Estimate, Sales $3.897M Miss $5.334M Estimate
OmniAb (NASDAQ:OABI) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.16) by 4.46 percent. This is a 15.38 percent decrease over losses of $(0.13) per share from the same
2025-08-07 06:51
OmniAb Affirms FY2025 Sales Guidance of $20.000M-$25.000M vs $22.970M Est
OmniAb (NASDAQ:OABI) affirms FY2025 sales outlook from $20.000 million-$25.000 million to $20.000 million-$25.000 million vs $22.970 million estimate.
2025-08-07 05:54
Benchmark Reiterates Buy on OmniAb, Maintains $6 Price Target
Benchmark analyst Robert Wasserman reiterates OmniAb (NASDAQ:OABI) with a Buy and maintains $6 price target.
2025-05-12 23:32
OmniAb Appoints New Directors to Board
The latest update is out from OmniAb ( ($OABI) ). On April 18, 2025, OmniAb, In...
2025-04-21 20:28
OmniAb, Inc. (OABI): 2024年第四季度业绩电话会议回顾及2025年展望
04.OmniAb, Inc. (OABI)2024年第四季度业绩电话会：2024年公司业务成果显著，活跃合作伙伴数量同比增长18%至91个，活跃项...
2025-03-21 06:41
